MS

Mamta Shukla

Active Director Director DIN 10077193
DIN 10077193 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mamta Shukla

Data last updated:

Mamta Shukla is a Director at Touchtweet Laboratories Private Limited (since 2023) and Director at Touchtweet Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma.

DIN 10077193
Primary Designation Director
Industry Pharma
First Appointment 17 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20232023Active
Director17 Mar 20232023Active

Board colleagues of Mamta Shukla

Directorship timeline

Open interactive timeline →
Touchtweet Pharmaceuticals Private Limited
Touchtweet Laboratories Private Limited
Premium access

Shareholding and investment profile for Mamta Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Shukla

Mamta Shukla currently holds 2 directorships: Touchtweet Laboratories Private Limited (Director, since 18 Aug 2023); Touchtweet Pharmaceuticals Private Limited (Director, since 17 Mar 2023).

Mamta Shukla was first appointed on 17 Mar 2023 as Director at Touchtweet Pharmaceuticals Private Limited.

The current boards of Mamta Shukla's companies include Jitendra Shukla (Touchtweet Laboratories Private Limited), Ajay Kumar (Touchtweet Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available